Quantitative indexes of β-cell function during graded up&down glucose infusion from C-peptide minimal models
- 1 January 2001
- journal article
- clinical trial
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 280 (1) , E2-E10
- https://doi.org/10.1152/ajpendo.2001.280.1.e2
Abstract
Availability of quantitative indexes of insulin secretion is important for definition of the alterations in β-cell responsivity to glucose associated with different physiopathological states. This is presently possible by using the intravenous glucose tolerance test (IVGTT) in conjunction with the C-peptide minimal model. However, the secretory response to a more physiological slowly increasing/decreasing glucose stimulus may uncover novel features of β-cell function. Therefore, plasma C-peptide and glucose data from a graded glucose infusion protocol (seven 40-min periods of 0, 4, 8, 16, 8, 4, and 0 mg · kg−1 · min−1) in eight normal subjects were analyzed by use of a new model of insulin secretion and kinetics. The model assumes a two-compartment description of C-peptide kinetics and describes the stimulatory effect on insulin secretion of both glucose concentration and the rate at which glucose increases. It provides in each individual the insulin secretion profile and three indexes of pancreatic sensitivity to glucose: Φs, Φd, and Φb, related, respectively, to the control of insulin secretion by the glucose level (static control), the rate at which glucose increases (dynamic control), and basal glucose. Indexes (means ± SE) were Φs = 18.8 ± 1.8 (109min−1), Φd = 222 ± 30 (109), and Φb = 5.2 ± 0.4 (109 min−1). The model also allows one to quantify the β-cell times of response to increasing and decreasing glucose stimulus, equal to 5.7 ± 2.2 (min) and 17.8 ± 2.0 (min), respectively. In conclusion, the graded glucose infusion protocol, interpreted with a minimal model of C-peptide secretion and kinetics, provides a quantitative assessment of pancreatic function in an individual. Its application to various physiopathological states should provide novel insights into the role of insulin secretion in the development of glucose intolerance.Keywords
This publication has 13 references indexed in Scilit:
- SAAM II: Simulation, analysis, and modeling software for tracer and pharmacokinetic studiesMetabolism, 1998
- Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.Journal of Clinical Investigation, 1997
- Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesityMetabolism, 1997
- Epinephrine Exerts Opposite Effects on Peripheral Glucose Disposal and Glucose-Stimulated Insulin Secretion: A Stable Label Intravenous Glucose Tolerance Test Minimal Model StudyDiabetes, 1996
- Estimation of β-Cell Sensitivity From Intravenous Glucose Tolerance Test C-Peptide Data: Knowledge of the Kinetics Avoids Errors in Modeling the SecretionDiabetes, 1995
- Insulin secretion and clearance during low-dose graded glucose infusionAmerican Journal of Physiology-Endocrinology and Metabolism, 1995
- Prehepatic Insulin Production in Man: Kinetic Analysis Using Peripheral Connecting Peptide Behavior*Journal of Clinical Endocrinology & Metabolism, 1980
- Characterization of Seven C-peptide AntiseraDiabetes, 1978
- Threshold secretory mechanism: A model of derivative element in biological controlBulletin of Mathematical Biology, 1973
- A threshold distribution hypothesis for packet storage of insulin and its mathematical modelingJournal of Clinical Investigation, 1972